AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.1974
+0.0053 (2.76%)
At close: Aug 24, 2026, 4:00 PM EDT
0.2067
+0.0093 (4.71%)
After-hours: Aug 24, 2026, 6:49 PM EDT
AEON Biopharma Employees
AEON Biopharma had 8 employees as of December 31, 2025. The number of employees increased by 3 or 60.00% compared to the previous year.
Employees
8
Change (1Y)
3
Growth (1Y)
60.00%
Revenue / Employee
n/a
Profits / Employee
-$6,827,875
Market Cap
9.85M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 8 | 3 | 60.00% |
| Dec 31, 2024 | 5 | -5 | -50.00% |
| Jun 30, 2024 | 5 | -4 | -44.44% |
| Dec 31, 2023 | 10 | 2 | 25.00% |
| Jun 30, 2023 | 9 | 0 | - |
| Dec 31, 2022 | 8 | - | - |
| Sep 30, 2022 | 9 | 3 | 50.00% |
| Jun 30, 2021 | 6 | - | - |
| Mar 31, 2021 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vistagen Therapeutics | 41 |
| Lunai Bioworks | 29 |
| OSR Health | 22 |
| Imunon | 20 |
| Theriva Biologics | 16 |
| FibroBiologics | 15 |
| Soligenix | 14 |
| MetaVia | 8 |
AEON News
- 10 hours ago - Aeon Biopharma designates Paul Lee as acting chief regulatory officer - TheFly
- 11 hours ago - AEON Biopharma Designates Former FDA Neuroscience Leader Paul Lee, M.D., Ph.D. as Acting Chief Regulatory Officer - GlobeNewsWire
- 5 days ago - AEON Reports Expanded Structural Data Supporting Molecular Similarity of ABP-450 to BOTOX® - GlobeNewsWire
- 8 days ago - Aeon Biopharma price target lowered to $1.20 from $5 at H.C. Wainwright - TheFly
- 12 days ago - AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 12 days ago - AEON Biopharma Earnings release: Q2 2026 - Filings
- 12 days ago - AEON Biopharma Quarterly report: Q2 2026 - Filings
- 13 days ago - AEON Biopharma Slides: Corporate presentation - Filings